--

Anna Schuh is a Professor of the University of Oxford and an honorary consultant in haematology at Oxford University Hospitals. Her main clinical and research interests are with lymphoid diseases (in particular chronic lymphocytic leukaemia) and molecular diagnostics.

Dr. Schuh is active in the field of reseach. She has been a principle investigator for over 50 clinical trials investigating new treatments for patients with leukaemias and lymphomas. As the head of the Oxford Molecular Diagnostic Centre, she leads on a research programme on improving response prediction for cancers, leukaemias and lymphomas using whole genome technologies and receives grants from NIHR, Wellcome Trust and Innovate UK.

As a result of her clinical practice and research achievements, she was asked to chair the UK's National Cancer Research Institute CLL working party.

Diseases, Medical Tests and Treatments

• Chemotherapy
• Leukaemia
• Molecular diagnostics
• Haematological oncology